Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Journal of Human Genetics|December 22, 2007
Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjectsKazuaki Miyake, Yukio Horikawa, Kazuo Hara, et al.
JCI Insight|May 8, 2020
GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levelsAyumi Kanno, Shun-Ichiro Asahara, Ayuko Furubayashi, et al.
Journal of Diabetes Investigation|March 27, 2025
Relation between obesity and health disorders as revealed by the J-ORBIT clinical information collection system directly linked to electronic medical records (J-ORBIT 1)Seiji Nishikage, Yushi Hirota, Yasushi Nakagawa, et al.
Data in Brief|June 15, 2018
Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery diseaseHiroyuki Yamamoto, Naofumi Yoshida, Toshiro Shinke, et al.
Atherosclerosis|February 7, 2018
Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patientsHiroyuki Yamamoto, Naofumi Yoshida, Toshiro Shinke, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2015
Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1cShun-ichiro Asahara, Hiroaki Etoh, Hiroyuki Inoue, et al.
Iscience|November 22, 2021
Bacteroides spp. promotes branched-chain amino acid catabolism in brown fat and inhibits obesityNaofumi Yoshida, Tomoya Yamashita, Tatsunori Osone, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 6, 2021
Assessment of the accuracy of an intermittent-scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) studyMasao Toyoda, Takashi Murata, Nobumichi Saito, et al.
Diabetology International|January 21, 2022
Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of ObesityAkira Sasaki, Koutaro Yokote, Takeshi Naitoh, et al.
Diabetology International|January 21, 2022
Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of ObesityAkira Sasaki, Koutaro Yokote, Takeshi Naitoh, et al.
Pageof 18